dpp 4 and glp 1 together DPP-4 inhibitors GLP-1RAs: cardiovascular safety and benefits JCI Insight - Hepatocyte-derived DPP4

Medicines regulator approves up to 7.2 mg dose of semaglutide (Wegovy) for patients with obesity only

New drugs and new advanced treatments such as the Tigertriever and Artemis are helping reduce the death and disability impact of stroke, as well as comprehensive care programs and innovative hospital partnerships that expand stroke services into rural areas

[DOI] [PubMed] [Google Scholar] 68.Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

Dual incretin agonists extend these effects by enhancing insulin sensitivity and modulating lipid metabolism through complementary receptor activation